Christopher Martell Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Christopher Martell is of Candel Therapeutics, Inc.. Currently has a direct ownership of 152,000 shares of CADL, which is worth approximately $1.33 Million. The most recent transaction as insider was on Dec 09, 2022, when has been sold 23,950 shares (Common Stock) at a price of $1.92 per share, resulting in proceeds of $45,984. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K
0% 3M change
0% 12M change
Total Value Held $1.33 Million

Christopher Martell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2022
BUY
Open market or private purchase
$45,984 $1.92 p/Share
23,950 Added 13.61%
152,000 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$5,124 $1.68 p/Share
3,050 Added 2.33%
128,050 Common Stock
CM

Christopher Martell

Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL